Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis
Status:
Completed
Trial end date:
2017-07-26
Target enrollment:
Participant gender:
Summary
This is a 12-week, open-label, dose-escalation Phase 1b study of a herbal treatment given
orally to subjects with ulcerative colitis. Subjects will be sequentially enrolled to one of
two cohorts in up to two clinical sites. Treatment will be given for 8 weeks and study
duration will be 12 weeks.